Jinsung Kim, CEO of Oncosoft, has won the ‘K-BioHealth Award’ in the ‘AI Cancer Treatment Software’ category for the third consecutive year at the 2025 11th Korea Industry Awards, hosted by Money Today.
Oncosoft specializes in AI-powered software for radiation cancer therapy. A company representative stated, "We are the only company in Korea that provides specialized radiation therapy solutions. We also have an AI auto-contouring product that has received approval from the Korean Ministry of Food and Drug Safety (MFDS)."
The company is also developing a platform for radiopharmaceutical cancer therapy and dosimetry-related products. In addition, Oncosoft has established a U.S. subsidiary and is preparing to enter global markets, including the U.S. and Japan.